Pre-tumour clones, periodic selection and clonal interference in the origin and progression of gastrointestinal cancer: Potential for biomarker development

Journal of Pathology

Volumn 229, Issue 4, 2013, Pages 502-514

  Baker, Ann Marie ^a   Graham, Trevor A ^b   Wright, Nicholas A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Barrett's oesophagus; field cancerization; inflammatory bowel disease; neutral mutations; pre tumour clones

Indexed keywords

MITOCHONDRIAL DNA; TUMOR MARKER;

CANCER GENETICS; CANCER GROWTH; DIGESTIVE SYSTEM CANCER; DNA DETERMINATION; DNA METHYLATION; GASTROINTESTINAL MUCOSA; GENE MUTATION; GENOME; HETEROZYGOSITY LOSS; HUMAN; MICROSATELLITE MARKER; MOLECULAR CLONING; PRECANCER; PRIORITY JOURNAL; REVIEW; X CHROMOSOME;

BIOLOGICAL MARKERS; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; DISEASE PROGRESSION; GASTRIC MUCOSA; GASTROINTESTINAL NEOPLASMS; HUMANS; INTESTINAL MUCOSA; MUTATION; PHENOTYPE; PRECANCEROUS CONDITIONS;

EID: 84874028404     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4157     Document Type: Review

References (113)

1. Foulds L., Neoplastic Development. Academic Press: London, 1975.
2. Nowell PC,. The clonal evolution of tumor cell populations. Science 1976; 194: 23-28.
3. Michor F, Frank SA, May RM, et al,. Somatic selection for and against cancer. J Theor Biol 2003; 225: 377-382.
4. Merlo LM, Pepper JW, Reid BJ, et al,. Cancer as an evolutionary and ecological process. Nat Rev Cancer 2006; 6: 924-935.
5. Greaves M., Darwinian medicine: a case for cancer. Nat Rev Cancer 2007; 7: 213-221.
6. Greaves M, Maley CC,. Clonal evolution in cancer. Nature 2012; 481: 306-313.
7. Mas A, Lopez-Galindez C, Cacho I, et al,. Unfinished stories on viral quasispecies and Darwinian views of evolution. J Mol Biol 2010; 397: 865-877.
8. Salk JJ, Salipante SJ, Risques RA, et al,. Clonal expansions in ulcerative colitis identify patients with neoplasia. Proc Natl Acad Sci USA 2009; 106: 20871-20876.
9. Thirlwell C, Will OC, Domingo E, et al,. Clonality assessment and clonal ordering of individual neoplastic crypts shows polyclonality of colorectal adenomas. Gastroenterology 2010; 138: 1441-1454, 1454 e1441-1447.
10. Jankowski JA, Odze RD,. Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol 2009; 104: 1093-1096.
11. Calabrese P, Tavare S, Shibata D,. Pretumor progression: clonal evolution of human stem cell populations. Am J Pathol 2004; 164: 1337-1346.
12. Barrett MT, Sanchez CA, Prevo LJ, et al,. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999; 22: 106-109.
13. Paulson TG, Galipeau PC, Xu L, et al,. p16 mutation spectrum in the premalignant condition Barrett's esophagus. PLoS One 2008; 3: e3809.
14. Wong DJ, Paulson TG, Prevo LJ, et al,. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 2001; 61: 8284-8289.
15. Barrett MT, Sanchez CA, Galipeau PC, et al,. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 1996; 13: 1867-1873.
16. Akagi T, Ito T, Kato M, et al,. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma. Int J Cancer 2009; 125: 2349-2359.
17. Brankley SM, Fritcher EG, Smyrk TC, et al,. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma. Hum Pathol 2012; 43: 172-179.
18. Gutierrez-Gonzalez L, Graham TA, Rodriguez-Justo M, et al,. The clonal origins of dysplasia from intestinal metaplasia in the human stomach. Gastroenterology 2011; 140: 1251-1260 e1251-1256.
19. Ushijima T, Sasako M,. Focus on gastric cancer. Cancer Cell 2004; 5: 121-125.
20. Ushijima T, Nakajima T, Maekita T,. DNA methylation as a marker for the past and future. J Gastroenterol 2006; 41: 401-407.
21. Eads CA, Lord RV, Kurumboor SK, et al,. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 2000; 60: 5021-5026.
22. Tamai O, Miyazato H, Shiraishi M, et al,. Morphologic and mucin histochemical analysis of transitional zones in advanced ulcerated colorectal carcinomas: potential prognostic indicators. J Surg Oncol 1998; 67: 85-89.
23. Aivado M, Gynes M, Gorelov V, et al,. [ 'Field cancerization'-an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms ]. Chirurgie 2000; 71: 1230-1234; discussion, 1234-1235.
24. Zhu D, Keohavong P, Finkelstein SD, et al,. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Cancer Res 1997; 57: 2485-2492.
25. Tobi M, Luo FC, Ronai Z,. Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma. J Natl Cancer Inst 1994; 86: 1007-1010.
26. Shen L, Kondo Y, Rosner GL, et al,. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005; 97: 1330-1338.
27. Graham TA, McDonald SA, Wright NA,. Field cancerization in the GI tract. Future Oncol 2011; 7: 981-993.
28. Ramirez N, Bandres E, Navarro A, et al,. Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions. Eur J Cancer 2008; 44: 2689-2695.
29. Nosho K, Kure S, Irahara N, et al,. A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 2009; 137: 1609-1620 e1601-1603.
30. Graham TA, Humphries A, Sanders T, et al,. Use of methylation patterns to determine expansion of stem cell clones in human colon tissue. Gastroenterology 2011; 140: 1241-1250 e1241-1249.
31. Stratton MR, Campbell PJ, Futreal PA,. The cancer genome. Nature 2009; 458: 719-724.
32. Salk JJ, Horwitz MS,. Passenger mutations as a marker of clonal cell lineages in emerging neoplasia. Semin Cancer Biol 2010; 20: 294-303.
33. Langeveld D, Jansen M, Brosens L, et al,. Diversity counts. Visualizing pretumor progression in the gastrointestinal tract. Am J Clin Pathol 2011; 135: 878-888.
34. Wright NA,. Stem cell identification-in vivo lineage analysis versus in vitro isolation and clonal expansion. J Pathol 2012; 227: 255-266.
35. Maley CC, Galipeau PC, Li X, et al,. Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res 2004; 64: 3414-3427.
36. Rubin AF, Green P,. Mutation patterns in cancer genomes. Proc Natl Acad Sci USA 2009; 106: 21766-21770.
37. Lyon MF,. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 1961; 190: 372-373.
38. Beutler E, Collins Z, Irwin LE,. Value of genetic variants of glucose-6-phosphate dehydrogenase in tracing the origin of malignant tumors. N Engl J Med 1967; 276: 389-391.
39. Linder D, Gartler SM,. Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science 1965; 150: 67-69.
40. Benditt EP, Benditt JM,. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973; 70: 1753-1756.
41. Novelli M, Cossu A, Oukrif D, et al,. X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. Proc Natl Acad Sci USA 2003; 100: 3311-3314.
42. Lander ES, Linton LM, Birren B, et al,. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
43. Salipante SJ, Kas A, McMonagle E, et al,. Phylogenetic analysis of developmental and postnatal mouse cell lineages. Evol Dev 2010; 12: 84-94.
44. Tsao JL, Yatabe Y, Salovaara R, et al,. Genetic reconstruction of individual colorectal tumor histories. Proc Natl Acad Sci USA 2000; 97: 1236-1241.
45. Tsao JL, Zhang J, Salovaara R, et al,. Tracing cell fates in human colorectal tumors from somatic microsatellite mutations: evidence of adenomas with stem cell architecture. Am J Pathol 1998; 153: 1189-1200.
46. Tomlinson IP, Lambros MB, Roylance RR,. Loss of heterozygosity analysis: practically and conceptually flawed? Genes Chromosomes Cancer 2002; 34: 349-353.
47. Pakendorf B, Stoneking M,. Mitochondrial DNA and human evolution. Annu Rev Genomics Hum Genet 2005; 6: 165-183.
48. Wallace DC,. Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci USA 1994; 91: 8739-8746.
49. Fellous TG, McDonald SA, Burkert J, et al,. A methodological approach to tracing cell lineage in human epithelial tissues. Stem Cells 2009; 27: 1410-1420.
50. Greaves LC, Preston SL, Tadrous PJ, et al,. Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc Natl Acad Sci USA 2006; 103: 714-719.
51. Taylor RW, Barron MJ, Borthwick GM, et al,. Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest 2003; 112: 1351-1360.
52. Yatabe Y, Tavare S, Shibata D,. Investigating stem cells in human colon by using methylation patterns. Proc Natl Acad Sci USA 2001; 98: 10839-10844.
53. Shibata D., Inferring human stem cell behaviour from epigenetic drift. J Pathol 2009; 217: 199-205.
54. Bronner MP, Skacel M, Crispin DA, et al,. Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors. Mod Pathol 2010; 23: 1624-1633.
55. Li X, Galipeau PC, Sanchez CA, et al,. Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression. Cancer Prev Res (Phila) 2008; 1: 413-423.
56. Metzker ML,. Sequencing technologies-the next generation. Nat Rev Genet 2010; 11: 31-46.
57. Salk JJ, Fox EJ, Loeb LA,. Mutational heterogeneity in human cancers: origin and consequences. Annu Rev Pathol 2010; 5: 51-75.
58. Schmitt MW, Kennedy SR, Salk JJ, et al,. Detection of ultra-rare mutations by next-generation sequencing. Proc Natl Acad Sci USA 2012; 109: 14508-14513.
59. Zhuang Z, Vortmeyer AO, Mark EJ, et al,. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res 1996; 56: 1961-1964.
60. Chaves P, Crespo M, Ribeiro C, et al,. Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved. Mod Pathol 2007; 20: 788-796.
61. Prevo LJ, Sanchez CA, Galipeau PC, et al,. p53-mutant clones and field effects in Barrett's esophagus. Cancer Res 1999; 59: 4784-4787.
62. Maley CC, Galipeau PC, Li X, et al,. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res 2004; 64: 7629-7633.
63. Maley CC,. Multistage carcinogenesis in Barrett's esophagus. Cancer Lett 2007; 245: 22-32.
64. Galipeau PC, Prevo LJ, Sanchez CA, et al,. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst 1999; 91: 2087-2095.
65. Maley CC, Galipeau PC, Finley JC, et al,. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 2006; 38: 468-473.
66. Merlo LM, Shah NA, Li X, et al,. A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev Res (Phila) 2010; 3: 1388-1397.
67. Slaughter DP,. The multiplicity of origin of malignant tumors: collective review. Internat Abstr Surg 1944; 79: 89-98.
68. Slaughter DP, Southwick HW, Smejkal W,. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-968.
69. Braakhuis BJ, Tabor MP, Kummer JA, et al,. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727-1730.
70. Hockel M, Dornhofer N,. The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection. Cancer Res 2005; 65: 2997-3002.
71. Leedham SJ, Graham TA, Oukrif D, et al,. Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. Gastroenterology 2009; 136: 542-550 e546.
72. Galandiuk S, Rodriguez-Justo M, Jeffery R, et al,. Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis. Gastroenterology 2012; 142: 855-864 e858.
73. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al,. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002; 161: 1051-1060.
74. Deng G, Lu Y, Zlotnikov G, et al,. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996; 274: 2057-2059.
75. Trujillo KA, Hines WC, Vargas KM, et al,. Breast field cancerization: isolation and comparison of telomerase-expressing cells in tumor and tumor-adjacent, histologically normal breast tissue. Mol Cancer Res 2011; 9: 1209-1221.
76. Franklin WA, Gazdar AF, Haney J, et al,. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 1997; 100: 2133-2137.
77. Preston SL, Wong WM, Chan AO, et al,. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res 2003; 63: 3819-3825.
78. Gutierrez-Gonzalez L, Deheragoda M, Elia G, et al,. Analysis of the clonal architecture of the human small intestinal epithelium establishes a common stem cell for all lineages and reveals a mechanism for the fixation and spread of mutations. J Pathol 2009; 217: 489-496.
79. Totafurno J, Bjerknes M, Cheng H,. The crypt cycle. Crypt and villus production in the adult intestinal epithelium. Biophys J 1987; 52: 279-294.
80. Cheng H, Bjerknes M, Amar J, et al,. Crypt production in normal and diseased human colonic epithelium. Anat Rec 1986; 216: 44-48.
81. Wong WM, Mandir N, Goodlad RA, et al,. Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut 2002; 50: 212-217.
82. Shih IM, Wang TL, Traverso G, et al,. Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci USA 2001; 98: 2640-2645.
83. Nystul T, Spradling A,. An epithelial niche in the Drosophila ovary undergoes long-range stem cell replacement. Cell Stem Cell 2007; 1: 277-285.
84. Eisenhoffer GT, Loftus PD, Yoshigi M, et al,. Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia. Nature 2012; 484: 546-549.
85. Marinari E, Mehonic A, Curran S, et al,. Live-cell delamination counterbalances epithelial growth to limit tissue overcrowding. Nature 2012; 484: 542-545.
86. Aktipis CA, Maley CC, Pepper JW,. Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility. Cancer Prev Res (Phila) 2012; 5: 266-275.
87. Jones S, Chen WD, Parmigiani G, et al,. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci USA 2008; 105: 4283-4288.
88. Desai MM, Fisher DS, Murray AW,. The speed of evolution and maintenance of variation in asexual populations. Curr Biol 2007; 17: 385-394.
89. Morata G, Ripoll P,. Minutes: mutants of Drosophila autonomously affecting cell division rate. Dev Biol 1975; 42: 211-221.
90. Moreno E, Basler K,. dMyc transforms cells into super-competitors. Cell 2004; 117: 117-129.
91. Rhiner C, Moreno E,. Super competition as a possible mechanism to pioneer precancerous fields. Carcinogenesis 2009; 30: 723-728.
92. Moreno E., Is cell competition relevant to cancer? Nat Rev Cancer 2008; 8: 141-147.
93. Pagliarini RA, Xu T,. A genetic screen in Drosophila for metastatic behavior. Science 2003; 302: 1227-1231.
94. Wu M, Pastor-Pareja JC, Xu T,. Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion. Nature 2010; 463: 545-548.
95. Thliveris AT, Halberg RB, Clipson L, et al,. Polyclonality of familial murine adenomas: analyses of mouse chimeras with low tumor multiplicity suggest short-range interactions. Proc Natl Acad Sci USA 2005; 102: 6960-6965.
96. Martens EA, Hallatschek O,. Interfering waves of adaptation promote spatial mixing. Genetics 2011; 189: 1045-1060.
97. Martens EA, Kostadinov R, Maley CC, et al,. Spatial structure increases the waiting time for cancer. New J Phys 2011; 13.
98. Nik-Zainal S, Van Loo P, Wedge DC, et al,. The life history of 21 breast cancers. Cell 2012; 149: 994-1007.
99. Shah SP, Morin RD, Khattra J, et al,. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009; 461: 809-813.
100. Gerlinger M, Rowan AJ, Horswell S, et al,. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-892.
101. Ekbom A, Helmick C, Zack M, et al,. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-359.
102. Langholz E, Munkholm P, Davidsen M, et al,. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992; 103: 1444-1451.
103. Rashid A, Hamilton SR,. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 1997; 113: 127-135.
104. Kern SE, Redston M, Seymour AB, et al,. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 1994; 107: 420-428.
105. Burmer GC, Rabinovitch PS, Haggitt RC, et al,. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 1992; 103: 1602-1610.
106. Chen R, Bronner MP, Crispin DA, et al,. Characterization of genomic instability in ulcerative colitis neoplasia leads to discovery of putative tumor suppressor regions. Cancer Genet Cytogenet 2005; 162: 99-106.
107. Rabinovitch PS, Dziadon S, Brentnall TA, et al,. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999; 59: 5148-5153.
108. Chen R, Rabinovitch PS, Crispin DA, et al,. DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. Am J Pathol 2003; 162: 665-672.
109. Rubin CE, Haggitt RC, Burmer GC, et al,. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992; 103: 1611-1620.
110. Brentnall TA, Crispin DA, Rabinovitch PS, et al,. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994; 107: 369-378.
111. Yoshida T, Mikami T, Mitomi H, et al,. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts. J Pathol 2003; 199: 166-175.
112. Lamlum H, Papadopoulou A, Ilyas M, et al,. APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci USA 2000; 97: 2225-2228.
113. Novelli MR, Williamson JA, Tomlinson IP, et al,. Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science 1996; 272: 1187-1190.